EMA recommends Merck's COVID antiviral molnupiravir for those at risk of severe illness
November 19 2021 - 1:06PM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2024 to May 2024
Merck (NYSE:MRK)
Historical Stock Chart
From May 2023 to May 2024